Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

812
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
812
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.2K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.2K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

378
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
378
Male Sexual Response: Erection & Ejaculation01:17

Male Sexual Response: Erection & Ejaculation

30.8K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
30.8K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

608
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
608

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Animal models of spinal cord injury in neuro-urological research.

Nature reviews. Urology·2026
Same author

Early multimodal neuromonitoring is associated with outcomes in critically ill patients with hemorrhagic stroke.

Frontiers in neurology·2026
Same author

Chronotype-based radiotherapy in localised prostate cancer: protocol for a prospective cohort integrating MCTQ and salivary DLMO.

Clinical and translational radiation oncology·2026
Same author

The Person Behind the Crime: Life Stories of Women and Men Who Committed Sexual Crimes.

Sexual abuse : a journal of research and treatment·2026
Same author

A Phase I trial of the anti-IL23 monoclonal antibody tildrakizumab, in combination with abiraterone acetate, for the treatment of metastatic castration-resistant prostate cancer.

Investigational new drugs·2026
Same author

Financial and occupational burden of leg ulcers in an active Portuguese tertiary hospital population: absenteeism, unemployment and retirement.

Journal of wound care·2026
Same journal

Efficacy of photodynamic therapy versus corticosteroid therapy for oral lichen planus: a systematic review and meta-analysis.

European journal of dermatology : EJD·2026
See all related articles

Related Experiment Video

Updated: Apr 25, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

38.4K

Erectile dysfunction in psoriasis patients.

Joana Cabete1, Tiago Torres2, Tiago Vilarinho3

  • 1Dermatology Department, Centro Hospitalar de Lisboa Central, Alameda Santo António dos Capuchos, 1169-050, Lisbon, Portugal.

European Journal of Dermatology : EJD
|August 15, 2014
PubMed
Summary
This summary is machine-generated.

Psoriasis significantly increases the risk of erectile dysfunction (ED). This study found psoriasis patients have higher ED prevalence and severity, suggesting it as an independent risk factor for ED.

Keywords:
erectile dysfunctionpsoriasis

More Related Videos

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

1.4K
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

1.1K

Related Experiment Videos

Last Updated: Apr 25, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

38.4K
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

1.4K
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

1.1K

Area of Science:

  • Dermatology
  • Urology
  • Cardiology

Background:

  • Psoriasis is linked to sexual dysfunction, but specific factors for erectile dysfunction (ED) remain unclear.
  • Understanding ED in psoriasis patients is crucial for comprehensive patient care.

Purpose of the Study:

  • To compare ED prevalence and severity in psoriasis patients versus controls.
  • To identify characteristics associated with ED in men with psoriasis.

Main Methods:

  • An observational, cross-sectional study involving 135 psoriasis patients and 201 controls.
  • Anonymous self-completed questionnaires assessed ED using the International Index of Erectile Function (IIEF).
  • Dermatology Life Quality Index (DLQI) was also utilized.

Main Results:

  • Psoriasis patients exhibited a higher prevalence of ED (61.5% vs 43.8%, p=0.001) and increased risk of severe ED.
  • Psoriasis itself was an independent risk factor for ED (OR 2.28).
  • Diabetes was also an independent risk factor (OR 3.49).

Conclusions:

  • Psoriasis is identified as a significant risk factor for erectile dysfunction.
  • Atherosclerosis and psychological factors likely contribute to ED in psoriasis.
  • ED may serve as an early marker for cardiovascular risk in men with psoriasis.